Table 4.

Donor (human) Cell/Progenitor Activity in Bone Marrow of Primary Sheep Recipients

AnimalColonies With Human Karyotype
CFU-MixCFU-GMBFU-E% CD45+ Cells4-150
No.%No.%No.%
770 9/290 3.1 60/1,000 6.0 14/609 2.3 1.41 ± 0.11 
771 8/186 4.3 29/763 3.8 1/281 1.3 ± 0.23 
772 0/162 17/370 4.6 11/500 2.2 0.7 ± 0.22 
775 8/381 2.1 79/887 8.9 19/306 6.2 1.7 ± 0.32 
AnimalColonies With Human Karyotype
CFU-MixCFU-GMBFU-E% CD45+ Cells4-150
No.%No.%No.%
770 9/290 3.1 60/1,000 6.0 14/609 2.3 1.41 ± 0.11 
771 8/186 4.3 29/763 3.8 1/281 1.3 ± 0.23 
772 0/162 17/370 4.6 11/500 2.2 0.7 ± 0.22 
775 8/381 2.1 79/887 8.9 19/306 6.2 1.7 ± 0.32 

Data from primary fetal recipients transplanted with 1.5 × 105 CD34+ cells/fetus are presented. As expected, donor cell activity was also detected in bone marrow of some animals transplanted with 1 × 106 primarily CD34+, AC133 cells/fetus. Bone marrow mononuclear cells obtained 1 week after birth were cultured in multiple methylcellulose plates as previously described.40 Total colony numbers were counted on days 9 and 19 of incubation; all 3 progenitor types (CFU-Mix, CFU-GM, and BFU-E) were detected on both days. On day 19, colonies were removed from the plate and individually processed for karyotyping.40 Percent values indicate the percentage of total colonies enumerated on day 9 (denominator) of culture that were determined to be of human origin (numerator) and were calculated as % human colonies = (no. of human colonies on day 19 × 100)/total no. of colonies on day 9.

F4-150

Each value represents the mean ± 1 SEM of results from 4 separate determinations at 1 week, 1 month, 2 months, and 3 months after birth. Expression of human cells was multilineage as determined by flow cytometric analysis of bone marrow with the following antibodies: CD34, 0.26%; CD4, 0.2%; CD5, 0.35%; CD13, 1.12%; CD14, 0.19%; gly A, 0.05%; CD33, 0.37%; CD7, 4.17%; CD13/CD45, 0.31%; CD5/CD10, 0.32%.

or Create an Account

Close Modal
Close Modal